Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India [0.03%]
来自南印度一家三级诊疗医院接种COVID-19疫苗后不良反应事件：90天内临床经验总结
Chetak Kadabasal Basavaraja,Juny Sebastian,Mandyam Dhati Ravi et al.
Chetak Kadabasal Basavaraja et al.
Background: The COVID-19 vaccination program was introduced in India on 16 January 2021. The Government-issued fact sheet was the only source of information regarding Adverse Events Following Immunizations (AEFIs) for the...
Jeremy Mayfield,Sumedha Bandi,Latha Ganti et al.
Jeremy Mayfield et al.
The authors of this article report on a case of a patient who presented to the emergency department (ED) in anaphylaxis after receiving the Moderna® COVID-19 vaccine. The patient was hypoxic, with diffuse wheezing bilaterally to auscultati...
Improving vaccine-related health literacy in parents: comparison on the readability of CDC Vaccine Information Statements (VIS) and Health and Human Services (HHS) patient-facing vaccine literature [0.03%]
提高父母的疫苗相关健康素养：比较CDC疫苗信息说明书(VIS)和卫生与公众服务部(HHS)面向患者的疫苗文献的可读性
Beverley C Millar,John E Moore
Beverley C Millar
Abdullahi Tunde Aborode,Emmanuel Adebowale Fajemisin,Osmond C Ekwebelem et al.
Abdullahi Tunde Aborode et al.
Michelle S Lee,Catherina X Pan,Vinod E Nambudiri
Michelle S Lee
The COVID-19 pandemic has necessitated rapid vaccine development for the control of the disease. Most vaccinations, including those currently approved for COVID-19 are administered intramuscularly and subcutaneously using hypodermic needles...
Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study [0.03%]
尼日利亚妊娠妇女的乙肝疫苗接种覆盖率：一项全国性试点横断面研究
George Uchenna Eleje,Godwin Otuodichinma Akaba,Ikechukwu Innocent Mbachu et al.
George Uchenna Eleje et al.
Objective: To determine the hepatitis B vaccination coverage, full-dose (⩾3) coverage and the associated factors affecting uptake among pregnant women. M...
Impact of educational intervention on the best immunization practices among practicing health care professionals in a south Indian city [0.03%]
教育干预对印度南部城市医护人员疫苗接种最佳实践的影响
Juny Sebastian,Gurumurthy Parthasarathi,Mandyam Dhati Ravi
Juny Sebastian
Background and aims: Maintaining the quality and safety of immunization is as important as the efficacy of vaccines in vaccine-preventable diseases (VPD) programs. The aim of this study was to determine the problems assoc...
Jane K Mills,Melissa A Henderson,Lauren Giuffrida et al.
Jane K Mills et al.
Background: Tumor-infiltrating lymphocytes (TILs) and chimeric antigen receptor (CAR) T-cell therapies have demonstrated promising, though limited, efficacy against melanoma. Methods: We designed a model system to explore the efficacy of du...
Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule? [0.03%]
在使用全细胞百日咳疫苗计划的地区给育龄期/孕妇接种百日咳吸附疫苗吗？
Abdoulreza Esteghamati,Shirin Sayyahfar,Yousef Alimohamadi et al.
Abdoulreza Esteghamati et al.
Background: Whole-cell pertussis (wP) vaccine administration is still advocated for children under 7 years of age in Iran. However, there is no recommendation for the administration of a dose of tetanus, diphtheria, and a...
Dengvaxia: the world's first vaccine for prevention of secondary dengue [0.03%]
登革热疫苗Dengvaxia：预防二次登革热世界首例疫苗问世
Danielle Tully,Carrie L Griffiths
Danielle Tully
The objective of this manuscript was to review and evaluate the efficacy and safety data of Dengvaxia for the treatment of severe secondary dengue infection. Dengvaxia is the brand name for chimeric yellow fever-dengue-tetravalent dengue va...